血球蛋白糖化指数和慢性心力衰竭中的死亡率:一个回顾性队列研究
Chuxin Lyu1,2,3, Yuan Gao1,2,3, Xinyu Tong4
1Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Medicine
|December 10, 2025
概括
较高的血红蛋白糖化指数 (HGI) 与住院慢性心力衰竭 (CHF) 患者的更好的生存率有关. 这项研究发现HGI与90天和365天全因死亡率有负相关性,白细胞计数部分介导了这一效应.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 临床研究 临床研究
背景情况:
- 慢性心力衰竭 (CHF) 是全球死亡的主要原因.
- 糖化血红蛋白 (HbA1c) 是血糖控制的标志物,但它在心血管疾病预后中的作用是复杂的.
- 血红蛋白糖化指数 (HGI) 提供了对血糖控制偏差的更个性化的评估.
研究的目的:
- 调查HGI与住院CHF患者的短期 (90天) 和长期 (365天) 全因死亡率 (ACM) 之间的关联.
- 探索HGI与死亡率之间的关系中的潜在调解因素.
- 确定HGI是否是该人群生存的独立预测因素.
主要方法:
- 来自MIMIC-IV数据库的2964名住院CHF患者的回顾性分析.
- 使用观察到和预测到的HbA1c计算HGI.
- 应用考克斯比例危险回归,限制立方线和卡普兰-梅尔曲线来评估死亡风险.
- 利用Boruta算法进行预测器识别和调解分析,以获得机械洞察力.
主要成果:
- 在CHF患者中,较高的HGI与90天和365天ACM的降低显著相关.
- 卡普兰-梅尔生存率分析显示,在最低的HGI四分位数中,生存率明显较低.
- HGI被确定为死亡率的独立预测因素,白细胞计数部分调解了这种关联.
结论:
- 在住院的CHF患者中,HGI与90天和365天的死亡率显著和负面相关.
- HGI独立地预测了CHF的更好的生存率,这种效应部分由白细胞数量介导.
- HGI可以作为一个有价值的预后生物标志物,用于管理住院的CHF患者.
相关概念视频
01:27Heart Failure I: Introduction
660
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
660
01:30Coronary Artery Disease I: Introduction
847
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
01:30Heart Failure IV: Classification and Diagnostic Evaluation
293
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
293
01:26Heart Failure III: Clinical Manifestations
440
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
440
01:29Heart Failure II: Pathophysiology
668
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668